Skip to main content
SpringerLink
Log in

Link between 5-αRIs and high-grade prostate cancer

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. O'Brien DC, Loeb S, McGuire BB, Hu Q, Catalona W.Long-Term 5-Alpha Reductase Inhibitor use is Associated with Adverse Clinico-Pathologic Features of Prostate Cancer. 106th Annual Meeting of the American Urological Association: abstr. 983, 14 May 2011. Available from: URL: http://www.aua2011.org

  2. Kjellman A, Friis S, Granath F, Gustafsson O, Sørensen HT, Akre O.Treatment with 5-Alpha Reductase Inhibitors and Prostate Cancer Survival. 106th Annual Meeting of the American Urological Association: abstr. 462, 14 May 2011. Available from: URL: http://www.aua2011.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Link between 5-αRIs and high-grade prostate cancer. React. Wkly. 1356, 4 (2011). https://doi.org/10.2165/00128415-201113560-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113560-00009

Keywords

Search

Navigation